Sven Q.
- Country
- Germany
- Department
- NA
Research Overview
- Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
Data & Insights
Has run more than one trial at 374 of 740 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating various forms of inflammatory dermatological conditions, with particular focus on atopic dermatitis and psoriasis. Their research encompasses both moderate and severe manifestations of these conditions.
- Atopic Dermatitis Management
- Plaque Psoriasis Treatment
- Hidradenitis Suppurativa
Autoimmune Skin Disorders
The investigator conducts research in autoimmune dermatological conditions, focusing on disorders affecting skin pigmentation and hair growth. Their work includes innovative therapeutic approaches for conditions like vitiligo and alopecia areata.
- Nonsegmental Vitiligo Treatment
- Pediatric Alopecia Management
- Chronic Urticaria Therapy
Skin Infections and Lesions
The investigator's expertise extends to treating fungal skin infections and precancerous lesions. Their research includes work on conditions such as actinic keratosis and various forms of candidiasis.
- Cutaneous Candidiasis Treatment
- Actinic Keratosis Management
- Prurigo Nodularis
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.